Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Voting Common Shares, no par value
-
Shares outstanding
-
51.9M
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
5.58M
-
Shares change
-
+514K
-
Total reported value, excl. options
-
$23.3M
-
Value change
-
+$2.25M
-
Put/Call ratio
-
0.02
-
Number of buys
-
21
-
Number of sells
-
-9
-
Price
-
$4.19
Significant Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q3 2024
46 filings reported holding DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value as of Q3 2024.
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.58M shares
of 51.9M outstanding shares and own 10.75% of the company stock.
Largest 10 shareholders include COOPERMAN LEON G (1.51M shares), VANGUARD GROUP INC (1.05M shares), FIRST MANHATTAN CO. LLC. (839K shares), PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE (483K shares), Bleichroeder LP (382K shares), GEODE CAPITAL MANAGEMENT, LLC (307K shares), LPL Financial LLC (141K shares), NORTHERN TRUST CORP (120K shares), MORGAN STANLEY (110K shares), and BlackRock, Inc. (108K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.